KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

GoodRx Holdings (GDRX) Receivables Refunds (2020 - 2022)

GoodRx Holdings (GDRX) has disclosed Receivables Refunds for 3 consecutive years, with $4.5 million as the latest value for Q4 2022.

  • Quarterly Receivables Refunds fell 45.7% to $4.5 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2022, down 45.7% year-over-year, with the annual reading at $4.5 million for FY2022, 45.7% down from the prior year.
  • Receivables Refunds hit $4.5 million in Q4 2022 for GoodRx Holdings, up from $2.2 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $79.8 million in Q2 2021 to a low of $2.2 million in Q3 2022.
  • Historically, Receivables Refunds has averaged $24.4 million across 3 years, with a median of $22.3 million in 2021.
  • Biggest five-year swings in Receivables Refunds: dropped 3.09% in 2021 and later tumbled 92.24% in 2022.
  • Year by year, Receivables Refunds stood at $28.6 million in 2020, then plummeted by 70.83% to $8.3 million in 2021, then crashed by 45.7% to $4.5 million in 2022.
  • Business Quant data shows Receivables Refunds for GDRX at $4.5 million in Q4 2022, $2.2 million in Q3 2022, and $16.8 million in Q2 2022.